FDA Circular No.2021-018-A || Extension of the Effectivity of FDA Circular No. 2021-018 Entitled “Updated Guidelines on the Identification, Notification, Evaluation, Regulatory Enforcement Action, and Review and Monitoring of Donated Health Products Solely Intended to Address the Covid-19 Public Health Emergency”

In the interest of service and due to the continuing COVID-19 Pandemic, the effectivity of FDA Circular No. 2021-018 entitled “Updated Guidelines on the Identification, Notification, Evaluation, Regulatory Enforcement Action, and Review and Monitoring of Donated Health Products Solely Intended to address the COVID-19 Public Health Emergency” is hereby extended and made coterminous with the duration of the public health emergency due to COVID-19 as declared in Proclamation No. 922, s. 2020, or the state of national calamity as declared in Proclamation No. 1218, s. 2021, whichever ends later.

For the information and guidance of the public.